Cannabis Strategic Ventures Stock Return On Equity
| NUGS Stock | USD 0.0001 0.00 0.00% |
Cannabis Strategic Ventures fundamentals help investors to digest information that contributes to Cannabis Strategic's financial success or failures. It also enables traders to predict the movement of Cannabis Pink Sheet. The fundamental analysis module provides a way to measure Cannabis Strategic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabis Strategic pink sheet.
Cannabis |
Cannabis Strategic Ventures Company Return On Equity Analysis
Cannabis Strategic's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Cannabis Strategic Ventures has a Return On Equity of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The return on equity for all United States stocks is 100.0% lower than that of the firm.
Cannabis Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannabis Strategic's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cannabis Strategic could also be used in its relative valuation, which is a method of valuing Cannabis Strategic by comparing valuation metrics of similar companies.Cannabis Strategic is currently under evaluation in return on equity category among its peers.
Cannabis Fundamentals
| Return On Asset | -0.2 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 25.44 M | |||
| Shares Outstanding | 268.88 M | |||
| Price To Book | 113.91 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 14.6 M | |||
| Gross Profit | 2.78 M | |||
| EBITDA | (4.93 M) | |||
| Net Income | (5.64 M) | |||
| Cash And Equivalents | 402.8 K | |||
| Total Debt | 21.67 M | |||
| Current Ratio | 0.21 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (4.09 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 30 | |||
| Beta | 1.34 | |||
| Market Capitalization | 3.54 M |
About Cannabis Strategic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabis Strategic Ventures's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabis Strategic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabis Strategic Ventures based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cannabis Pink Sheet Analysis
When running Cannabis Strategic's price analysis, check to measure Cannabis Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Strategic is operating at the current time. Most of Cannabis Strategic's value examination focuses on studying past and present price action to predict the probability of Cannabis Strategic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Strategic's price. Additionally, you may evaluate how the addition of Cannabis Strategic to your portfolios can decrease your overall portfolio volatility.